Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Orthopedics, University Medical Center Utrecht, Utrecht, the Netherlands.
Cancer. 2019 Dec 1;125(23):4224-4231. doi: 10.1002/cncr.32420. Epub 2019 Aug 13.
A critical knowledge gap exists regarding the impact of neurologic deficits on surgical outcomes and health-related quality of life (HRQOL) for patients surgically treated for metastatic epidural spinal cord compression (MESCC).
This prospective, multicenter and international study analyzed the impact of the neurologic status on functional status, HRQOL, and postoperative survival. The collected data included the patient demographics, overall survival, American Spinal Injury Association (ASIA) impairment scale, Spinal Instability Neoplastic Score, treatment details and complications and HRQOL measures, including version 2 of the 36-Item Short Form Health Survey (SF-36v2) and version 2.0 of the Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ2.0).
A total of 239 patients surgically treated for spinal metastases were included. Six weeks after treatment, 99 of the 108 patients with a preoperative ASIA grade of E remained stable, 8 deteriorated to ASIA D, and 1 deteriorated to ASIA A. Of 55 patients with ASIA D, 27 improved to ASIA E, 27 remained stable and 1 deteriorated to ASIA C. Of 11 patients with ASIA A to C, 2 improved to ASIA E, 4 improved to ASIA D, and 5 remained stable. At the 6- and 12-week follow-up, better ASIA scores were associated with better scores on multiple SF-36v2 and SOSGOQ items. Postoperatively, patients with ASIA grades of A to D were more likely to have urinary tract infections and wound complications. Patients with a baseline ASIA grade of E or D survived significantly longer.
Patients with neurologic deficits due to MESCC have worse HRQOL and decreased overall survival. Nevertheless, surgery can result in stabilization or improvement of neurologic function which may translate into better HRQOL. Postoperative care and follow-up are challenging for patients with neurologic deficits because they experience more complications.
在接受转移性硬膜外脊髓压迫症(MESCC)手术治疗的患者中,神经功能缺陷对手术结果和健康相关生活质量(HRQOL)的影响是一个关键的知识空白。
这项前瞻性、多中心和国际化研究分析了神经状态对功能状态、HRQOL 和术后生存的影响。收集的数据包括患者人口统计学、总生存、美国脊髓损伤协会(ASIA)损伤量表、脊柱不稳定肿瘤评分、治疗细节和并发症以及 HRQOL 测量,包括第 2 版 36 项简明健康调查量表(SF-36v2)和脊柱肿瘤研究组结果问卷(SOSGOQ2.0)第 2.0 版。
共纳入 239 例接受脊柱转移瘤手术治疗的患者。在治疗后 6 周时,108 例术前 ASIA 分级为 E 的患者中有 99 例保持稳定,8 例恶化至 ASIA D,1 例恶化至 ASIA A。55 例 ASIA D 患者中,27 例改善至 ASIA E,27 例保持稳定,1 例恶化至 ASIA C。11 例 ASIA A 至 C 患者中,2 例改善至 ASIA E,4 例改善至 ASIA D,5 例保持稳定。在 6 周和 12 周的随访中,更好的 ASIA 评分与多个 SF-36v2 和 SOSGOQ 项目的更好评分相关。术后,ASIA 分级为 A 至 D 的患者更易发生尿路感染和伤口并发症。基线 ASIA 分级为 E 或 D 的患者存活时间显著更长。
由于 MESCC 导致神经功能缺陷的患者 HRQOL 较差,总生存时间缩短。尽管如此,手术可以使神经功能稳定或改善,这可能转化为更好的 HRQOL。神经功能缺陷的患者术后护理和随访具有挑战性,因为他们会经历更多的并发症。